Literature DB >> 9736711

Transformation of hematopoietic cells by the Ski oncoprotein involves repression of retinoic acid receptor signaling.

R Dahl1, M Kieslinger, H Beug, M J Hayman.   

Abstract

The Ski oncogene has dramatic effects on the differentiation of several different cell types. It induces the differentiation of quail embryo cells into myoblasts and arrests the differentiation of chicken hematopoietic cells. The mechanism that Ski uses to carry out these disparate biological activities is unknown. However, we were struck by the similarity of these effects to those of certain members of the nuclear hormone receptor family. Both Ski and the thyroid hormone receptor-derived oncogene v-ErbA can arrest the differentiation of avian erythroblasts, and v-Ski-transformed avian multipotent progenitor cells resemble murine hematopoietic cells that express a dominant-negative form of the retinoic acid receptor, RARalpha. In this paper, we have tested the hypothesis that v-Ski and its cellular homologue c-Ski exert their effects by interfering with nuclear hormone receptor-induced transcription. We demonstrate that Ski associates with the RAR complex and can repress transcription from a retinoic acid response element. The physiological significance of this finding is demonstrated by the ability of high concentrations of a RARalpha-specific ligand to abolish v-Ski-induced transformation of the multipotent progenitors. These results strongly suggest that the ability of Ski to alter cell differentiation is caused in part by the modulation of RAR signaling pathways.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9736711      PMCID: PMC21617          DOI: 10.1073/pnas.95.19.11187

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Activation of Stat 5b in erythroid progenitors correlates with the ability of ErbB to induce sustained cell proliferation.

Authors:  G Mellitzer; O Wessely; T Decker; A Meinke; M J Hayman; H Beug
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

2.  Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus.

Authors:  A Rascle; N Ferrand; O Gandrillon; J Samarut
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

3.  In vitro growth of factor-dependent multipotential hematopoietic cells is induced by the nuclear oncoprotein v-Ski.

Authors:  H Beug; R Dahl; P Steinlein; S Meyer; E M Deiner; M J Hayman
Journal:  Oncogene       Date:  1995-07-06       Impact factor: 9.867

4.  Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor.

Authors:  A J Hörlein; A M Näär; T Heinzel; J Torchia; B Gloss; R Kurokawa; A Ryan; Y Kamei; M Söderström; C K Glass
Journal:  Nature       Date:  1995-10-05       Impact factor: 49.962

5.  A transcriptional co-repressor that interacts with nuclear hormone receptors.

Authors:  J D Chen; R M Evans
Journal:  Nature       Date:  1995-10-05       Impact factor: 49.962

6.  PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors.

Authors:  Z Chen; F Guidez; P Rousselot; A Agadir; S J Chen; Z Y Wang; L Degos; A Zelent; S Waxman; C Chomienne
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

7.  Teratogenicity of low doses of all-trans retinoic acid in presomite mouse embryos.

Authors:  K K Sulik; D B Dehart; J M Rogers; N Chernoff
Journal:  Teratology       Date:  1995-06

8.  A carboxyl-terminal region of the ski oncoprotein mediates homodimerization as well as heterodimerization with the related protein SnoN.

Authors:  H C Heyman; E Stavnezer
Journal:  J Biol Chem       Date:  1994-10-28       Impact factor: 5.157

9.  Activation of a muscle-specific enhancer by the Ski proto-oncogene.

Authors:  J C Engert; S Servaes; P Sutrave; S H Hughes; N Rosenthal
Journal:  Nucleic Acids Res       Date:  1995-08-11       Impact factor: 16.971

Review 10.  The nuclear receptor superfamily: the second decade.

Authors:  D J Mangelsdorf; C Thummel; M Beato; P Herrlich; G Schütz; K Umesono; B Blumberg; P Kastner; M Mark; P Chambon; R M Evans
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

View more
  20 in total

1.  SKIP, a CBF1-associated protein, interacts with the ankyrin repeat domain of NotchIC To facilitate NotchIC function.

Authors:  S Zhou; M Fujimuro; J J Hsieh; L Chen; A Miyamoto; G Weinmaster; S D Hayward
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

2.  Ski can negatively regulates macrophage differentiation through its interaction with PU.1.

Authors:  N Ueki; L Zhang; M J Hayman; M J Haymann
Journal:  Oncogene       Date:  2007-07-09       Impact factor: 9.867

3.  Chromosomal instability in mouse embryonic fibroblasts null for the transcriptional co-repressor Ski.

Authors:  Katherine Marcelain; Ricardo Armisen; Adam Aguirre; Nobuhide Ueki; Jessica Toro; Clemencia Colmenares; Michael J Hayman
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

4.  Strain-specific modifier genes governing craniofacial phenotypes.

Authors:  Partha Mukhopadhyay; Guy Brock; Cynthia Webb; M Michele Pisano; Robert M Greene
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-02-28

5.  Peroxisome proliferator-activated receptor γ (PPARγ) mediates a Ski oncogene-induced shift from glycolysis to oxidative energy metabolism.

Authors:  Fang Ye; Hélène Lemieux; Charles L Hoppel; Richard W Hanson; Parvin Hakimi; Colleen M Croniger; Michelle Puchowicz; Vernon E Anderson; Hisashi Fujioka; Ed Stavnezer
Journal:  J Biol Chem       Date:  2011-09-14       Impact factor: 5.157

6.  The sno gene, which encodes a component of the histone deacetylase complex, acts as a tumor suppressor in mice.

Authors:  T Shinagawa; H D Dong; M Xu; T Maekawa; S Ishii
Journal:  EMBO J       Date:  2000-05-15       Impact factor: 11.598

7.  Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor.

Authors:  W Xu; K Angelis; D Danielpour; M M Haddad; O Bischof; J Campisi; E Stavnezer; E E Medrano
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

8.  The crystal structure of the Dachshund domain of human SnoN reveals flexibility in the putative protein interaction surface.

Authors:  Tomas Nyman; Lionel Trésaugues; Martin Welin; Lari Lehtiö; Susanne Flodin; Camilla Persson; Ida Johansson; Martin Hammarström; Pär Nordlund
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

9.  The Ski protein can inhibit ligand induced RARalpha and HDAC3 degradation in the retinoic acid signaling pathway.

Authors:  Hong-Ling Zhao; Nobuhide Ueki; Katherine Marcelain; Michael J Hayman
Journal:  Biochem Biophys Res Commun       Date:  2009-03-31       Impact factor: 3.575

Review 10.  Ski and SnoN, potent negative regulators of TGF-beta signaling.

Authors:  Julien Deheuninck; Kunxin Luo
Journal:  Cell Res       Date:  2009-01       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.